Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Oncurie Logo
Oncurie Growth Score
27
CB Rank
119500
Heat Score
66
Oncurie focuses on creating the technology to deliver radionuclides selectively to metastatic tissue to treat metastatic cancer.
Founded
obfuscation
PrivateGrant Raleigh, North Carolina, United States1-10 oncurie.com
Biotechnology
Chemical Engineering
Health Care
Therapeutics
Overview

Oncurie
Total Funding
obfuscation
Growth Score
27
Heat Score
66

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score27
-2 pts
in past quarter
Heat Score 66
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Oncurie

CB Rank
119500
Oncurie focuses on creating the technology to deliver radionuclides selectively to metastatic tissue to treat metastatic cancer.
Founded
obfuscation
PrivateGrant Raleigh, North Carolina, United States1-10 oncurie.com
Biotechnology
Chemical Engineering
Health Care
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Details

Legal Name Oncurie, Inc.
Operating Status Active
Company Type For Profit
About the Company
Oncurie develops targeted radionuclide therapy to create a cure for metastatic cancer through the use of novel molecular radionuclide technology, enabling healthcare providers to cure their patients. They are creating the technology to deliver radionuclides selectively to metastatic tissues.
Predictions & Insights

Growth Insight

See this Growth Insight
Oncurie is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

Ovarian Cancer Theranostics
A compound developed to deliver radioisotopes to ovarian cancer cells, currently undergoing preclinical studies.
Radiopharmaceutical Innovation
Development of novel chelators to explore new regions of the periodic table for cancer treatment.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Oncurie Logo
Grant - Oncurie
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Oncurie Logo
Grant - Oncurie
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Oncurie Logo
Grant - Oncurie
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Oncurie Logo
Grant - Oncurie
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Oncurie Logo
Grant - Oncurie
1
obfuscation
One North Carolina Small Business ProgramGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Oncurie Logo
Grant - Oncurie
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Oncurie Logo
Grant - Oncurie
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Oncurie Logo
Grant - Oncurie
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Oncurie Logo
Grant - Oncurie
1
obfuscation
One North Carolina Small Business ProgramGrant
obfuscation
Grant - Oncurie Logo
Grant - Oncurie
1
obfuscation
One North Carolina Small Business ProgramGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 2
News

News and Press

News•Oct 15, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$247KThis year, Oncurie is projected to spend $247K on IT, according to Aberdeen.

Active Website Tech Count

2Oncurie is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Oncurie's headquarters? Oncurie is located in Raleigh, North Carolina, United States.Who invested in Oncurie? Oncurie has 2 investors including One North Carolina Small Business Program and  National Science Foundation.When was the last funding round for Oncurie? Oncurie closed its last funding round on
obfuscation
from a Grant round.Who are Oncurie's competitors? Alternatives and possible competitors to Oncurie may include Novartis, Bayer, and  Telix Pharmaceuticals.How much funding has Oncurie raised to date? Oncurie has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(7280375 1)
|